Straits Times Index
3,283.24 -9.89 (-0.30%) Nikkei
37,689.96 -770.12 (-2.00%) Hang Seng
17,295.93 +94.66 (+0.55%) FTSE 100
8,040.38 -4.43 (-0.06%) Bitcoin USD
64,310.96 -2,582.59 (-3.86%) CMC Crypto 200
1,388.57 -35.53 (-2.50%)
Humana Inc (HUM.MU)
| Previous close | 306.20 |
| Open | 306.20 |
| Bid | 294.80 x N/A |
| Ask | 295.80 x N/A |
| Day's range | 306.20 - 313.00 |
| 52-week range | 282.90 - 495.00 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 24 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Yahoo Finance Video
Humana stock slides on pullback for 2025 forecast
Shares of Humana (HUM) slide Wednesday morning as the health insurance company reported its first-quarter earnings, revealing $29.61 billion in total revenue for the quarter, an increase of 10% year-over-year, however, the company pulled back its full-year 2025 forecast. The company cites disappointing Medicare reimbursement rates from the US government as a reason for the pullback. Yahoo Finance Health Reporter Anjalee Khemlani breaks down the first-quarter results and what challenges the insurer faces moving forward. For more expert insight and the latest market action, click here to watch this full episode. This post was written by Nicholas Jacobino
BenzingaHumana Withdraws Its Already Lowered 2025 Profit Guidance
On Wednesday, Humana Inc (NYSE:HUM), in its first quarter earnings remarks, said the company withdrew its already lowered 2025 profit forecast, citing disappointing government Medicare Advantage (MA) reimbursement rates. The insurance firm said the final MA rate notice is not sufficient to address the current medical cost trend environment. Humana’s medical benefit ratio – the percentage of premiums spent on medical care – rose to 88.9% in the first quarter. In its fourth quarter 2023 earnings r
